Last reviewed · How we verify
SYNTHETIC CONJUGATED ESTROGENS, B — Competitive Intelligence Brief
marketed
Live · refreshed every 30 min
Target snapshot
SYNTHETIC CONJUGATED ESTROGENS, B (SYNTHETIC CONJUGATED ESTROGENS, B).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SYNTHETIC CONJUGATED ESTROGENS, B TARGET | SYNTHETIC CONJUGATED ESTROGENS, B | marketed | 2004-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SYNTHETIC CONJUGATED ESTROGENS, B CI watch — RSS
- SYNTHETIC CONJUGATED ESTROGENS, B CI watch — Atom
- SYNTHETIC CONJUGATED ESTROGENS, B CI watch — JSON
- SYNTHETIC CONJUGATED ESTROGENS, B alone — RSS
Cite this brief
Drug Landscape (2026). SYNTHETIC CONJUGATED ESTROGENS, B — Competitive Intelligence Brief. https://druglandscape.com/ci/synthetic-conjugated-estrogens-b. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab